Skip to main content
logo
Idorsia Ltd (SWX:IDIA)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
3.450
-0.085 (-2.40%)
Mar 13, 2026, 4:15 PM CET

Idorsia Revenue

In the year 2025, Idorsia had annual revenue of 220.58M CHF with 96.06% growth. Idorsia had revenue of 47.97M in the quarter ending December 31, 2025, a decrease of -19.91%.

Revenue
220.58M
Revenue Growth
+96.06%
P/S Ratio
4.03
Revenue / Employee
339.36K
Employees
650
Market Cap
889.08M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025220.58M108.08M96.06%
Dec 31, 2024112.51M-39.88M-26.17%
Dec 31, 2023152.39M55.28M56.93%
Dec 31, 202297.10M61.75M174.70%
Dec 31, 202135.35M-36.41M-50.74%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Basilea Pharmaceutica AG232.38M
Newron Pharmaceuticals55.93M
Santhera Pharmaceuticals Holding AG49.02M
BioVersys AG1.31M
Xlife Sciences AG839.38K
Molecular Partners AG681.00K
Addex Therapeutics158.54K
Revenue Rankings

Idorsia News

More News